Why is Chemo Pharma Lab falling/rising?

As of 30-Sep, Chemo Pharma Laboratories Ltd is experiencing a decline in its stock price, currently at Rs 114.00, which reflects a decrease of Rs 7.9 or 6.48%. The stock has underperformed its sector by 5.77% today and opened with a loss of 5.41%. It reached an intraday low of Rs 114, indicating significant selling pressure. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend. Notably, investor participation has fallen sharply, with delivery volume dropping by 98.96% compared to the 5-day average, indicating a lack of interest from investors. There are no positive or negative factors provided that could further explain the stock's recent movement.
In the broader market context, Chemo Pharma's short-term performance over the past week shows a decline of 6.48%, which is significantly worse than the Sensex's decline of 2.23%. Over the past month, the stock has also decreased by 4.00%, contrasting with the Sensex's modest gain of 0.57%. Despite a strong performance in the longer term, with a year-to-date increase of 3.79% compared to the Sensex's 2.72%, the recent downturn highlights a concerning trend for Chemo Pharma Laboratories Ltd in the current market environment.